Filters
on 01 May 2019
BRISTOL-MYERS SQUIBB COMPANY (A DELAWARE CORPORATION)
1776486 · 08 Apr 2016
005
Class 005
Pharmaceutical Products
Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, stroke, cancer, respiratory diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use relating to metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, anti-inflammatories, anti-infectives, central nervous system depressants, central nervous system stimulants, anti-psychotics; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for the treatment of cancer, respiratory diseases, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for use as anti-infectives, and for use as anti-inflammatories; diagnostic pharmaceutical preparations for human use for increasing the heart rate and for use as medical imaging contrast agents
Pharmaceutical preparations for human use for the treatment and preven...
on 19 Feb 2015
GLAXO GROUP LIMITED
1701718 · 07 Nov 2014
005
Class 005
Pharmaceutical Products
Pharmaceutical preparations for use as anti-infectives; Pharmaceutical preparations for the treatment of viral conditions, namely human immunodeficiency virus (HIV), HPV, RSV, hepatitis, herpes genitalis, herpes labialis, herpes simplex virus, varicella-zoster virus, Epstein-Barr virus and cytomegalovirus; Pharmaceutical preparations for the treatment and prevention of respiratory diseases and disorders and their symptoms; Pharmaceutical preparations for the treatment of immune system related diseases and disorders, namely immunosuppressants; Pharmaceutical preparations for the treatment of immunologic diseases and disorders namely, autoimmune diseases and disorders; Pharmaceutical preparations for the treatment of atherosclerosis; Pharmaceutical preparations for the treatment and prevention of metabolic related diseases and disorders namely disorders of the endocrine system, namely growth and thyroid disorders, diabetes, metabolic syndrome, obesity, weight loss and weight management; Pharmaceutical preparations for the treatment and prevention of cardiovascular, cardiopulmonary, cardio-renal and renal diseases and disorders; Pharmaceutical preparations for the prevention and treatment of oncological diseases and disorders; Pharmaceutical preparations for the treatment of inflammation and inflammatory related diseases and disorders namely arthritis, rheumatoid arthritis, inflammatory bowel diseases, inflammatory connective tissue diseases, vasculitis, synovitis; Pharmaceutical preparations for the prevention and treatment of sequelae of oncologic diseases and their treatment namely nausea and vomiting, hematologic depression, mucositis, cachexia, pain, bone pain and fatigue; Pharmaceutical preparations for the treatment of blood-related diseases and disorders namely thrombocytopenia, coagulation disorders, bleeding disorders, platelet disorders, blood vessel disorders, sickle-cell disease and its related disorders, anemias, sepsis and infections in and of the blood; Pharmaceutical preparations for the treatment of musculoskeletal diseases, disorders and injuries namely connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, gout, fractures, sprains, sports injuries, osteogenesis imperfecta, muscle wasting (cachexia), renal osteodystrophy, cartilage injuries, joint replacement and osteoarthritis; Pharmaceutical preparations for use in ophthalmology; Pharmaceutical preparations for the treatment of dermatological diseases and disorders namely dermatitis, skin and skin structure infections namely bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections, psoriasis, eczema and sexually transmitted diseases; Pharmaceutical preparations for the treatment of hormonal related diseases and disorders namely hypogonadism, testosterone/androgen disorders and estrogen disorders; Pharmaceutical preparations for the treatment of gastrointestinal related diseases and disorders namely irritable bowel disorders and symptoms, digestive disorders and acid-related disorders; Pharmaceutical preparations for the treatment of sexual dysfunction namely erectile dysfunction, male and female sexual dysfunction disorders namely arousal disorder, pain disorder, desire disorder and orgasm disorder; Pharmaceutical preparations for the treatment of genitourinary diseases namely urological diseases and disorders; Pharmaceutical preparations for the treatment of gynaecological diseases and disorders namely amenorrhoea, dysmenorrheal and infertility; Pharmaceutical hormonal preparations namely corticosteroids, hormone replacement therapy preparations, oral contraceptives, thyroid hormone preparations; Pharmaceutical preparations for the treatment of incontinence, prostate diseases and disorders, bladder diseases and disorders; Pharmaceutical preparations for the treatment of sexually transmitted diseases, inflammatory pelvic diseases, vasomotor/menopausal symptoms, endometriosis/uterine fibroids, Leiomyoma, endourology/stone, pre-eclampsia and pre-term labour; Pharmaceutical preparations for the treatment of prostatitis, nephritis, cystitis, vaginitis, renal disease; Pharmaceutical preparations for the treatment of premenstrual dysphoric disorder, premenstrual syndrome, male hypogonadism and hormonal disorders namely polycystic ovary syndrome; Pharmaceutical preparations for the treatment of hepatological related diseases namely hepatitis, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), liver fibroids, and cirrhosis; Pharmaceutical preparations for the treatment of alopecia and androgenic alopecia (male pattern baldness); Pharmaceutical preparations for the treatment of psychiatric diseases and disorders namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia, and psychoses; Pharmaceutical preparations for the treatment of damaged skin and tissue namely bee stings, sunburn, rashes, sores, corns, calluses and acne; Pharmaceutical preparations for the treatment of inflammatory connective tissue diseases and injuries; Pharmaceutical preparations for the treatment of malaria; Pharmaceutical preparations for the treatment of tuberculosis; Allergy medications; Vaccines namely prophylactic and therapeutic vaccines for humans; Pharmaceutical preparations for the treatment of neurological diseases and disorders namely Parkinson's Disease, Alzheimer's Disease, Huntington's Disease, dementia, migraine, cerebral palsy, brain injury, spinal cord injury, seizure disorders, epilepsy, restless legs syndrome, pain, neuropathic pain, inflammatory-related pain, fibromyalgia, stroke, multiple sclerosis, insomnia; Pharmaceutical preparations for the treatment of central nervous system diseases and disorders namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, depression and anxiety and their related disorders namely schizophrenia and psychoses; Pharmaceutical preparations for the treatment of muscular dystrophy
044
Class 044
Medical, Beauty & Agricultural Services
Cell and gene therapy services
Cell and gene therapy services,Pharmaceutical preparations for use as ...
on 11 May 2016
BRISTOL-MYERS SQUIBB COMPANY (A DELAWARE CORPORATION)
1477580 · 20 Apr 2010
005
Class 005
Pharmaceutical Products
Pharmaceutical preparations for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, stroke, cancer, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, anti-inflammatories, anti-infectives, anti-psychotics, central nervous system depressants, central nervous system stimulants, pharmaceutical preparations for the treatment of the respiratory system.
Pharmaceutical preparations for the treatment and prevention of obesit...
on 17 Oct 2012
HASBRO INC.
1453173 · 25 Sep 2009
028
Class 028
Toys and Sporting Goods Products
Plush toy animals.
Plush toy animals.
on 06 Apr 2011
ELI LILLY AND COMPANY
1339039 · 13 Mar 2007
005
Class 005
Pharmaceutical Products
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorders, anxiety, bone and skeletal diseases and disorders, blood disorders, namely Non-Hodgkins Lymphoma, Burkitts Lymphoma, Waldenstroms Macroglobulinemia, Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia, Chronic Lymphocytic Leukemia, Multiple Myeloma, cancer, cardiovascular diseases, central nervous system diseases and disorders, namely anxiety disorders, depression; bipolar depression, bipolar disorder, treatment resistant depression, schizophrenia, cognitive impairment associated with schizophrenia, diabetes, endocrine diseases and disorders, namely, type 1 diabetes mellitus and type 2 diabetes mellitus, gastrointestinal diseases and disorders, hormonal diseases and disorders, namely vasomotor symptoms, hot flashes, inflammation and inflammatory diseases and disorders, namely, rheumatoid arthritis, liver diseases and disorders, kidney diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, namely, Alzheimers disease, mild cognitive impairment, Parkinsons disease, obesity, pain, namely, chronic pain, neuropathic pain, non-neuropathic pain, non-inflammatory pain, inflammatory pain, visceral pain, reproductive system diseases and disorders, urological disorders, dyslipidemia, sleep disorders, migraines, metabolic diseases and disorders, antipsychotic agents; and antidepressants.
Pharmaceutical preparations, namely, pharmaceutical preparations for ...
on 02 Jul 2021
NATRAZAHOR S.A.
1246605 · 09 Feb 2005
030
Class 030
Staple Food Products
Chocolate and chocolates.
Chocolate and chocolates.
on 25 Aug 2010
BRISTOL-MYERS SQUIBB COMPANY (A DELAWARE CORPORATION)
1225844 · 04 Aug 2004
005
Class 005
Pharmaceutical Products
Pharmaceutical preparations for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, stroke, cancer, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, anti-inflammatories, anti-infectives, anti-psychotics, central nervous system depressants, central nervous system stimulants, pharmaceutical preparations for the treatment of the respiratory system.
Pharmaceutical preparations for the treatment and prevention of obesit...
Country
CA
Status
All
Registered
Pending
Abandoned
Other
Owners
Bristol-myers squibb company (a delaware corporation) (1)
Bristol-myers squibb company (a delaware corporation) (1)
Bristol-myers squibb company (a delaware corporation) (1)
Eli lilly and company (1)
Glaxo group limited (1)
Hasbro inc.. (1)
Natrazahor s.A. (1)
Categories
Class 5 (5)
Class 28 (1)
Class 30 (1)
Class 44 (1)
Correspondents
Gowling wlg (canada) llp (4)
Smart & biggar ip agency co. (1)
Smart & biggar lp (1)
Image Search
Drag and drop or upload to search any image
End of search results
Page 1 of 1